Skip to main content
Caplight Logo









Cannaray CBD

Cannaray CBD

Private
LondonHealthcare & Life Scienceshttps://cannaraycbd.com

Last Round

VC Round

Apr 4, 2022

Total Funding Raised

$9.6M

Company Overview

Cannaray CBD operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a VC Round in April 2022.

Cannaray CBD is a wellness company that supplies premium, lab-tested CBD oils, capsules, gummies, and topicals.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Cannaray CBD Comparables

Compare Cannaray CBD with similar companies based on industry and business-model similarity.

Cannaray CBD comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Montu
80%
Integro Medical Clinics
79%
Curaleaf
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Cannaray CBD Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 4, 2022
Series ASep 9, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Cannaray CBD Investors

Notable investors and investment history

Cannaray CBD investors
InvestorRounds
Channel 4 VenturesVC Round
Three Bridges Private CapitalVC Round
Alpha Blue OceanVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 50% MoM, reaching 26K.

  • May 3, 2025

    Monthly visitors grew 72% MoM, reaching 21.7K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Cannaray CBD Filings

Explore SEC and related filing metadata, where available.

Cannaray CBD filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Cannaray CBD's valuation, stock price, and market status.

Is Cannaray CBD a public or private company?

Cannaray CBD is a private company.

What is the current stock price of Cannaray CBD?

Cannaray CBD is a private company, so its shares have no public market price. Caplight tracks Cannaray CBD's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cannaray CBD worth (valuation)?

Valuation information for Cannaray CBD is not publicly available.

Can I buy Cannaray CBD stock?

Cannaray CBD shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cannaray CBD's last funding round?

Cannaray CBD's most recent funding round was VC Round on April 4, 2022.

Who are the main investors in Cannaray CBD?

Key investors in Cannaray CBD include Channel 4 Ventures, Three Bridges Private Capital, Alpha Blue Ocean.

Will Cannaray CBD IPO soon?

No public IPO plans have been announced for Cannaray CBD.

How can I track Cannaray CBD secondary market activity?

Caplight tracks bids, offers, and trades in Cannaray CBD's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range17
Year Founded2019
Last FundingApr 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?